NuCana PLC ADR (NCNA)
followers
·
Follow
Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Hugh S. Griffith
Employees:
30
3 LOCHSIDE WAY, EDINBURGH, X0, EH12 9DT
44-0-131-357-1111
NuCana plc engages in the development of products for the treatment of cancer. Its lead product candidate includes Acelarin, which is in Phase I clinical trial for patients with advanced solid tumors. The company is also developing NUC-3373, a ProTide transformation of the active anti-cancer metabolite of 5-fluorouracil.
All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
---|